JP2022507013A5 - - Google Patents
Info
- Publication number
- JP2022507013A5 JP2022507013A5 JP2021521390A JP2021521390A JP2022507013A5 JP 2022507013 A5 JP2022507013 A5 JP 2022507013A5 JP 2021521390 A JP2021521390 A JP 2021521390A JP 2021521390 A JP2021521390 A JP 2021521390A JP 2022507013 A5 JP2022507013 A5 JP 2022507013A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- compound
- ring
- group
- condensed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1817047.2A GB201817047D0 (en) | 2018-10-19 | 2018-10-19 | H4 antagonist compounds |
| GB1817047.2 | 2018-10-19 | ||
| PCT/GB2019/052997 WO2020079457A1 (en) | 2018-10-19 | 2019-10-21 | Pyrazole derivatives as h4 antagonist compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022507013A JP2022507013A (ja) | 2022-01-18 |
| JP2022507013A5 true JP2022507013A5 (cg-RX-API-DMAC10.html) | 2022-10-31 |
| JP7532353B2 JP7532353B2 (ja) | 2024-08-13 |
Family
ID=64453795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521390A Active JP7532353B2 (ja) | 2018-10-19 | 2019-10-21 | Ｈ４アンタゴニスト化合物としてのピラゾール誘導体 |
Country Status (13)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202005858D0 (en) * | 2020-04-22 | 2020-06-03 | Heptares Therapeutics Ltd | H4 Antagonist compounds |
| GB202019667D0 (en) * | 2020-12-14 | 2021-01-27 | Heptares Therapeutics Ltd | H4 antagonist comnpounds |
| KR102655210B1 (ko) * | 2021-03-26 | 2024-04-08 | 주식회사 스탠다임 | 아데노신 a2a 수용체 길항제 및 이의 용도 |
| WO2022232259A1 (en) * | 2021-04-28 | 2022-11-03 | Cornell University | Soluble adenylyl cyclase (sac) inhibitors and uses thereof |
| EP4421067A4 (en) * | 2021-10-19 | 2026-01-14 | Unimatec Co Ltd | PYRAZOLE COMPOUND CONTAINING FLUORIDE AND ITS PRODUCTION PROCESS |
| KR102621694B1 (ko) * | 2022-09-15 | 2024-01-08 | 주식회사 스탠다임 | 아데노신 a2a 수용체 길항제 및 이의 용도 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000169475A (ja) | 1998-07-24 | 2000-06-20 | Dai Ichi Seiyaku Co Ltd | ピラゾ―ル誘導体およびその塩 |
| US6573377B1 (en) * | 1998-07-24 | 2003-06-03 | Daiichi Pharmaceuticals Co., Ltd. | Pyrazole derivatives and salts thereof |
| WO2005054239A1 (en) | 2003-12-05 | 2005-06-16 | Bayer Healthcare Ag | 2-aminopyrimidine derivatives |
| NL2000323C2 (nl) * | 2005-12-20 | 2007-11-20 | Pfizer Ltd | Pyrimidine-derivaten. |
| EP2066645A2 (en) | 2006-09-12 | 2009-06-10 | UCB Pharma S.A. | 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions |
| US7985745B2 (en) | 2006-10-02 | 2011-07-26 | Abbott Laboratories | Method for pain treatment |
| CL2008000467A1 (es) | 2007-02-14 | 2008-08-22 | Janssen Pharmaceutica Nv | Compuestos derivados de 2-aminopirimidina, moduladores del receptor histamina h4; su procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno inflamatorio seleccionado de alegia, asma |
| WO2009068512A1 (en) | 2007-11-30 | 2009-06-04 | Palau Pharma, S. A. | 2 -amino-pyrimidine derivatives as histamine h4 antagonists |
| PE20091524A1 (es) | 2007-12-19 | 2009-09-25 | Palau Pharma Sa | Derivados de 2-aminopirimidina |
| RU2489430C2 (ru) | 2007-12-21 | 2013-08-10 | Палау Фарма, С.А. | Производные 4-аминопиримидина |
| AR074199A1 (es) | 2008-11-20 | 2010-12-29 | Glaxosmithkline Llc | Compuesto de 6-(4-pirimidinil)-1h-indazol, composiciones farmaceuticas que lo comprenden y su uso para preparar un medicamento util para el tratamiento o disminucion de la gravedad del cancer. |
| TW201035078A (en) | 2009-03-20 | 2010-10-01 | Incyte Corp | Substituted heterocyclic compounds |
| WO2011059839A1 (en) | 2009-10-29 | 2011-05-19 | Sirtris Pharmaceuticals, Inc. | Bicyclic pyridines and analogs as sirtuin modulators |
| JP5781537B2 (ja) | 2009-12-23 | 2015-09-24 | メディシス ファーマシューティカル コーポレイション | ヒスタミンｈ４受容体アンタゴニストとしてのアミノアルキルピリミジン誘導体 |
| AR093512A1 (es) | 2012-11-16 | 2015-06-10 | Merck Patent Gmbh | Derivados heterociclicos como moduladores de la actividad de cinasas |
| JP2019525929A (ja) | 2016-07-28 | 2019-09-12 | メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ | Ｐａｒｋｉｎ酵素機能の小分子活性化因子 |
-
2018
- 2018-10-19 GB GBGB1817047.2A patent/GB201817047D0/en not_active Ceased
-
2019
- 2019-10-21 WO PCT/GB2019/052997 patent/WO2020079457A1/en not_active Ceased
- 2019-10-21 MX MX2021004280A patent/MX2021004280A/es unknown
- 2019-10-21 ES ES19794235T patent/ES3058587T3/es active Active
- 2019-10-21 EP EP19794235.2A patent/EP3867248B1/en active Active
- 2019-10-21 JP JP2021521390A patent/JP7532353B2/ja active Active
- 2019-10-21 CA CA3116628A patent/CA3116628A1/en active Pending
- 2019-10-21 US US17/285,776 patent/US12234227B2/en active Active
- 2019-10-21 BR BR112021007372-8A patent/BR112021007372A2/pt unknown
- 2019-10-21 AU AU2019360428A patent/AU2019360428B2/en active Active
- 2019-10-21 KR KR1020217014805A patent/KR102873380B1/ko active Active
- 2019-10-21 CN CN201980084053.7A patent/CN113272297B/zh active Active
- 2019-10-21 SG SG11202103133QA patent/SG11202103133QA/en unknown
-
2024
- 2024-09-05 US US18/826,098 patent/US20250115587A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2008143457A (ru) | Производные-2-пиразинона для лечения заболевания или состояния, при которых полезно ингибирование активности нейтрофильной эластазы | |
| RU2353616C2 (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| JP2024525580A5 (cg-RX-API-DMAC10.html) | ||
| CA2522024A1 (en) | Cgrp receptor antagonists | |
| JP2024542692A5 (cg-RX-API-DMAC10.html) | ||
| RU2008133383A (ru) | Производные гидантоина для лечения воспалительных заболеваний | |
| ES2605388T3 (es) | Compuesto inhibidor de Trk | |
| JP2014505037A5 (cg-RX-API-DMAC10.html) | ||
| JP2009536197A5 (cg-RX-API-DMAC10.html) | ||
| JP2021523221A5 (cg-RX-API-DMAC10.html) | ||
| ME02672B (me) | Fenil-3-aza-bicikl0[3.1.0]heks-3-il-metanoni i njihova primena kao medikament | |
| HRP20201494T1 (hr) | Spojevi heteroaril-karboksamida kao inhibitori ripk2 | |
| JP2016532669A5 (cg-RX-API-DMAC10.html) | ||
| JP2017511357A5 (cg-RX-API-DMAC10.html) | ||
| JP2005508960A5 (cg-RX-API-DMAC10.html) | ||
| JP2018522032A5 (cg-RX-API-DMAC10.html) | ||
| RU2018127360A (ru) | Производные бензимидазола в качестве модуляторов ror-гамма | |
| SI2970314T1 (en) | Substituted 2-azabicycles and their use as orexin receptor modulators | |
| JP2010510242A5 (cg-RX-API-DMAC10.html) | ||
| JP2022519239A5 (cg-RX-API-DMAC10.html) | ||
| US20170275260A1 (en) | Allosteric modulators of nicotinic acetylcholine receptors | |
| RU2016115934A (ru) | Конденсированное гетероциклическое соединение, способ его получения, его фармацевтическая композиция и применения | |
| JP2020521766A5 (cg-RX-API-DMAC10.html) | ||
| HRP20230643T1 (hr) | Derivati benzimidazola kao modulatori receptora siroče gama (rory) povezanih s retinoidima i njihova farmaceutska upotreba | |
| JP2025506667A5 (cg-RX-API-DMAC10.html) |